PodParley PodParley
PodParley
Could Ozempic, and other GLP-1 drugs, be changing more than your waistline? episode artwork

EPISODE · Jul 10, 2026 · 16 MIN

Could Ozempic, and other GLP-1 drugs, be changing more than your waistline?

from Newell Normand

New research suggests popular GLP-1 drugs may also affect the brain’s reward and impulse-control systems. What does it mean for patients, and could these medications have uses beyond weight loss? Newell has on Dr. Gil Hebert, Assistant Professor of Medicine at Tulane University, to talk about it.

Episode metadata supplied by the publisher feed · Published Jul 10, 2026

Embed this episode

NOW PLAYING

Could Ozempic, and other GLP-1 drugs, be changing more than your waistline?

0:00 16:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

The Eric Normand Podcast Eric Normand An off-the-cuff stream of Functional Programming ideas, skills, patterns, and news from Functional Programming expert Eric Normand of LispCast. Formerly known as Thoughts on Functional Programming.

Frequently Asked Questions

How long is this episode of Newell Normand?

This episode is 16 minutes long.

When was this Newell Normand episode published?

This episode was published on July 10, 2026.

Can I download this Newell Normand episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!